Results 151 to 160 of about 51,767 (241)

Nanoscopic Mapping of the Extracellular Space in Amyloid Plaque‐rich Cortex

Advanced Science, Volume 13, Issue 1, 5 January 2026.
The extracellular space and diffusion around amyloid plaques are examined using shadow imaging and single‐particle tracking. Increased diffusivity is found near plaques, extracellular matrix alterations, and plaque core penetrability that varies with amyloid phenotype.
Juan Estaún‐Panzano, Yulia Dembitskaya, Ivo Calaresu, Somen Nandi, Quentin Gresil, Evelyne Doudnikoff, Thierry Leste‐Lasserre, Thierry Amédée, Laurent Cognet, Laurent Groc, Urs Valentin Nägerl, Erwan Bezard   +11 more
wiley   +1 more source

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns. [PDF]

Biomedicines
Mitrovic M, Sretenovic A, Kecman N, Vukosavljevic N, Perunicic Jovanovic M, Sobic Saranovic D, Maksimovic R, Bukumiric Z, Lekovic D, Ristic A, Todorovic Balint M, Bila J.   +11 more
europepmc   +1 more source

Presenting features, treatment patterns and predictors of outcomes in AL amyloidosis at a tertirary care cancer centre [PDF]

Aditya Nair, Dhyey Mishra, Archit Shirpurkar, Arjun Singh, Arpit Arora, Debdeep Samaddar, Lingaraj Nayak, Alok Shetty, Prashant Tembhare, Nishant Jindal, Sumeet Mirgh, Anant Gokarn, Sachin Punatar, Sweta Rajpal, Gaurav Chatterjee, Nikhil Patkar, PG Subramanian, Dhanlaxmi Shetty, H. K. Jain, Hasmukh Jain, Manju Sengar, Navin Khattry, Bhausaheb Bagal   +22 more
openalex   +1 more source

CSF proteomic profiling with amyloid and tau pathology identifies distinctive sex‐specific alteration of multiple proteins involved in Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION In Alzheimer's disease (AD), females have higher prevalence and faster progression, but sex‐specific molecular findings in AD are limited. METHODS We comprehensively examined 6162 proteins in cerebrospinal fluid (CSF) from 2496 participants to identify sex‐specific proteomic alteration by CSF amyloid beta (Aβ)42 and phosphorylated
Anh N. Do, Soomin Song, Muhammad Ali, Jigyasha Timsina, Lihua Wang, Daniel Western, Menghan Liu, Jessie Sanford, Matitee Rosende‐Roca, Merce Boada, Raquel Puerta, Edward N. Wilson, Agustin Ruiz, Pau Pastor, the Alzheimer's Disease Neuroimaging Initiative (ADNI), Tony Wyss‐Coray, Carlos Cruchaga, Yun Ju Sung   +17 more
wiley   +1 more source

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era. [PDF]

Hemasphere
Bazarbachi AH, Zanwar S, Hegenbart U, Trajanova D, Bhutani D, Gertz MA, Dispenzieri A, Kumar S, D'Souza A, Patwari A, Cowan A, Chen G, Milani P, Palladini G, Sanchorawala V, Bodanapu G, Mohty M, Lentzsch S, Schönland SO, Muchtar E, Chakraborty R.   +20 more
europepmc   +1 more source

Kidney Carbuncle in a Patient with Primary Systemic Al-Amyloidosis and Nephortic Syndrome

, 2021
Amina M. Alieva, M. A. Batov, I. I. Almazova, Irina E. Baykova, A. S. Tikhomirova, R. K. Valiev, И. Г. Никитин   +6 more
openalex   +2 more sources

Defining patient‐centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION Amyloid‐induced tauopathy drives clinical decline in Alzheimer's disease (AD). Because age and sex shape tau trajectories, defining patient‐centered amyloid thresholds for tauopathy onset could facilitate pre‐tauopathy AD identification and aid treatment decisions and prognosis.
Zeyu Zhu, Anna Steward, Amir Dehsarvi, Sebastian N. Roemer‐Cassiano, Anna Dewenter, Davina Biel, Fabian Hirsch, Lukas Frontzkowski, Julia Pescoller, Madleen Klonowski, Johannes Gnörich, Michael J. Pontecorvo, Sergey Shcherbinin, Michael Schöll, Rachel Buckley, Rik Ossenkoppele, Fang Xie, Tengfei Guo, Alzheimer's Disease Neuroimaging Initiative, Günter Höglinger, Matthias Brendel, Nicolai Franzmeier   +21 more
wiley   +1 more source

Frequency-adjusted daratumumab-based regimen versus bortezomib/dexamethasone in newly diagnosed AL amyloidosis: a matched-cohort study. [PDF]

Ann Med
Zheng W, Zhou M, Xing Y, Zhao J, Liu B, Li W, Sun S.   +6 more
europepmc   +1 more source

Rotational Mechanics of the Left Ventricle in AL Amyloidosis

, 2010
Maria Cristina Porciani, Francesco Cappelli, Federico Perfetto, M Ciaccheri, Gabriele Castelli, Ilaria Ricceri, Marco Chiostri, Franco Bergesio, Luigi Padeletti   +8 more
openalex   +2 more sources

Multi‐omic expression of the VEGF family relates to Alzheimer's disease across diverse populations

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION The vascular endothelial growth factor (VEGF) signaling family plays a role in neurodegenerative diseases, including Alzheimer's disease (AD). Previous work has shown widespread effects of the members FLT1, FLT4, and VEGFB on AD outcomes. However, these analyses have focused within the non‐Hispanic White (NHW) population.
Julia B. Libby, Kacie D. Deters, Nilüfer Ertekin‐Taner, Minerva M. Carrasquillo, Mariet Allen, Philip De Jager, Vilas Menon, Bin Zhang, Vahram Haroutunian, Allan I. Levey, Nicholas T. Seyfried, Rima Kaddurah‐Daouk, Steve Finkbeiner, Daifeng Wang, Anna K. Greenwood, Abby Vander Linden, Laura Heath, William L. Poehlman, Logan Dumitrescu, Vladislav A. Petyuk, David A. Bennett, Julie A. Schneider, Lisa L. Barnes, Timothy J. Hohman   +23 more
wiley   +1 more source